Effects of Adverse Events on the Projected Population Benefits and Cost-effectiveness of Using Live Attenuated Influenza Vaccine in Children Aged 6 Months to 4 Years

This publication has 27 references indexed in Scilit:

• Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
  New England Journal of Medicine, 2007
• Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children
  Emerging Infectious Diseases, 2006
• Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections
  The Pediatric Infectious Disease Journal, 2006
• Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma
  The Pediatric Infectious Disease Journal, 2006
• Burden of Interpandemic Influenza in Children Younger than 5 Years: A 25‐Year Prospective Study
  The Journal of Infectious Diseases, 2002
• Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience
  The Pediatric Infectious Disease Journal, 2001
• Influenza virus infections in infants
  The Pediatric Infectious Disease Journal, 1997
• Acute respiratory illness in the community. Frequency of illness and the agents involved
  Epidemiology and Infection, 1993
• TECUMSEH STUDY OF ILLNESS. XIII. INFLUENZA INFECTION AND DISEASE, 1976–1981
  American Journal of Epidemiology, 1985
• Influenza Surveillance in the Pacific Northwest 1976–1980
  International Journal of Epidemiology, 1983